Company to share preclinical data across diverse pipeline of iNK, γδ iT, and αβ iT cell therapy programs for oncology and autoimmune disease ...
Five BriaCell poster presentations to highlight updated survival and key biomarker data from Phase 2 trial of Bria-IMTâ„¢ plus immune check point ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback